In addition, this result is consistent with the experiences accumulated with both SARS-CoV-1 infection and severe influenza that show how patients receiving CP transfusion early after symptom onset had better outcomes and revealed consistent evidence for a reduction in mortality (Cheng et al., 2005; Mair-Jenkins et al., 2015). Here, CP is linked to influenza.